ABOS
Acumen Pharmaceuticals Inc
2.20$
-3.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +4,125.0% | +8.9% | -3.3% | -521.9% | |
| – | -11.5% | +498.7% | +232.0% | +100.8% | +56.8% | +2.3% | |
| – | -234.6% | – | -96.3% | – | – | – | |
| – | -60.0% | -2.9% | +1,237.6% | -3.0% | +201.4% | -143.9% | |
| – | +0.0% | +0.0% | +302.5% | -87.0% | -23.8% | +450.0% | |
| – | +0.0% | +0.0% | – | -538.1% | – | +178.9% | |
| – | – | – | – | – | – | – | |
| – | – | – | -97.7% | -100.0% | – | +78.0% | |
| – | – | – | – | – | -102.5% | -100.0% | |
| – | +616.1% | +348.7% | -98.1% | +3,784.1% | -95.4% | -100.5% | |
| – | – | +110.6% | -89.9% | -893.3% | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.